Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10,962 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hypofractionated Simultaneous Integrated Boost Radiotherapy Versus Conventional Fractionation Radiotherapy of Early Breast Cancer After Breast-Conserving Surgery: Clinical Observation and Analysis.
Dong J, Yang Y, Han D, Zhao Q, Liu C, Sun H, Wang Z, Lin H, Huang W. Dong J, et al. Among authors: han d. Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211064719. doi: 10.1177/15330338211064719. Technol Cancer Res Treat. 2021. PMID: 34898315 Free PMC article.
Phase III study of cisplatin with pemtrexed or vinorelbine plus concurrent late course accelerated hyperfractionated radiotherapy in patients with unresectable stage III non-small cell lung cancer.
Zhao Q, Wang Z, Huang W, Wang Q, Yu S, Zhou T, Han D, Wu Z, Gong H, Sun H, Zhang J, Wei Y, Li H, Zhang Z, Lin H, Li B. Zhao Q, et al. Among authors: han d. Oncotarget. 2016 Feb 16;7(7):8422-31. doi: 10.18632/oncotarget.6871. Oncotarget. 2016. PMID: 26761213 Free PMC article. Clinical Trial.
High dose radiation therapy based on normal tissue constraints with concurrent chemotherapy achieves promising survival of patients with unresectable stage III non-small cell lung cancer.
Zhao Q, Liu M, Wang Z, Huang W, Allen Li X, Zhou T, Zhang J, Zhang Z, Wang Q, Yu S, Han D, Sun H, Li H, Lin H, Li B. Zhao Q, et al. Among authors: han d. Radiother Oncol. 2020 Apr;145:7-12. doi: 10.1016/j.radonc.2019.11.024. Epub 2019 Dec 21. Radiother Oncol. 2020. PMID: 31869678
Twice-daily thoracic radiotherapy by intensity-modulated radiation therapy (IMRT) compared with simultaneous integrated boost IMRT (SIB-IMRT) with concurrent chemotherapy for patients with limited-stage small cell lung cancer. A propensity-score matched analysis.
Sun H, Liu C, Zhang J, Yang G, Han D, Liu T, Huang W, Li B. Sun H, et al. Among authors: han d. Radiother Oncol. 2022 Jul;172:140-146. doi: 10.1016/j.radonc.2022.01.022. Epub 2022 Jan 29. Radiother Oncol. 2022. PMID: 35101460
10,962 results
You have reached the last available page of results. Please see the User Guide for more information.